Collection: PDGFRA D842V
-
Dasatinib 70mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).
Regular price ¥400.00 CNYRegular priceUnit price / per¥880.00 CNYSale price ¥400.00 CNYSale -
Dasatinib 50mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).
Regular price ¥320.00 CNYRegular priceUnit price / per¥680.00 CNYSale price ¥320.00 CNYSale -
Dasatinib 20mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).
Regular price ¥180.00 CNYRegular priceUnit price / per¥480.00 CNYSale price ¥180.00 CNYSale